# Phio Pharmaceuticals Corp.: Form DEF 14A, filed May 8, 2024

- Company: [Phio Pharmaceuticals Corp.](/companies/phio.md) (CIK 1533040)
- Form: DEF 14A
- Filed: 2024-05-08
- Accepted by EDGAR: May 8, 2024, 17:02 ET
- Period: 2024-06-17
- Accession: 0001683168-24-003113
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533040/000168316824003113/phio_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533040/000168316824003113/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533040/000168316824003113/phio_def14a.htm

Filed May 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001683168-24-003113. Last ingested by Listed: Nov 12, 2026, 20:44 ET. No prices; not investment advice.
